openPR Logo
Press release

Vitamin D May Prevent Severe COVID-19 Disease And Death

New research from Trinity College and University of Edinburgh has examined the association between vitamin D and COVID-19, and found that ambient ultraviolet B (UVB) radiation (which is key for vitamin D production in the skin) at an individual's place of residence in the weeks before COVID-19 infection, was strongly protective against severe disease and death.

Previous studies have linked vitamin D deficiency with an increased susceptibility to viral and bacterial respiratory infections. Similarly, several observational studies found a strong correlation between vitamin D deficiency and COVID-19, but it could be that these effects are confounded and in fact a result of other factors, such as obesity, older age or chronic illness which are also linked with low vitamin D.

To overcome this, researchers were able to calculate "genetically-predicted" vitamin D level, that is not confounded by other demographic, health and lifestyle factors, by using the information from over one hundred genes that determine vitamin D status.

The Mendelian Randomisation is a particular analytical approach that enabled researchers to investigate whether vitamin D and COVID-19 might be causally linked using genetic data.

What is unique about this research?

Researchers, for the first time, looked at both genetically-predicted and UVB-predicted vitamin D level. Almost half a million individuals in the UK took part in the study, and ambient UVB radiation before COVID-19 infection was individually assessed for each participant. When comparing the two variables, researchers found that correlation with measured vitamin D concentration in the circulation was three-fold stronger for UVB-predicted vitamin D level, compared to genetically-predicted.

What were the findings?

Researchers found that ambient UVB radiation at an individual's place of residence preceding COVID-19 infection was strongly and inversely associated with hospitalization and death. This suggests that vitamin D may protect against severe COVID-19 disease and death. Additionally, while the results from the Mendelian Randomisation analysis weren't conclusive, some indication of a potential causal effect was noted. Because of the relatively weak link between genetically-predicted vitamin D level that is used for Mendelian Randomisation analysis, it is possible that the number of cases in the current study was too small to convincingly determine causal effect, but future larger studies might provide the answer.

Professor Lina Zgaga, associate professor in epidemiology, School of Medicine, Trinity College and senior researcher on the study said: "Our study adds further evidence that vitamin D might protect against severe COVID-19 infection. Conducting a properly designed COVID-19 randomized controlled trial of vitamin D supplementation is critical. Until then, given that vitamin D supplements are safe and cheap, it is definitely advisable to take supplements and protect against vitamin D deficiency, particularly with winter on the horizon."

As a leading and professional manufacturer, Huateng Pharma provides fine chemicals, PEG derivatives, biochemical reagents, pharmaceutical intermediates, APIs, Vitamin D Derivatives for our customers. We committed to providing cost-effective pharmaceutical products and services to customers around the world with the belief of “Strive for the Human Health".

Address:Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China
Email: sales@huatengusa.com
Website:https://en.huatengsci.com
Zip code: 410205
Telephone: +86 731 89916275

Human Huateng Pharmaceutical Co., Ltd. is a leading and professional manufacturer which can provide pharmaceutical intermediates, PEG derivatives, biochemical reagents, APIs, Vitamin D Derivatives and so on. We are committed to providing cost-effective pharmaceutical products and services to customers around the world with the belief of “Strive for the Human Health".

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vitamin D May Prevent Severe COVID-19 Disease And Death here

News-ID: 2423562 • Views: 864

More Releases from Hunan Huateng Pharmaceutical Co. Ltd.

Huateng Pharma Develops Systemic Antiparasitic Agent Fluralaner
Fluralaner is a systemic insecticide and acaricide that can be administered orally or topically. Bravecto is the trade name. The U.S. Food and Drug Administration (FDA) approved it for flea treatment in dogs under the trade name Bravecto in May 2014 and for topical treatment in cats in November 2019. Fluralaner is a novel isooxazoline broad-spectrum insecticide that acts on γ-aminobutyric acid (GABA) receptors and has good activity against ticks, fleas,
Huateng Pharma Develops Intermediates of Carfilzomib For Multiple Myeloma
Carfilzomib, a proteasome inhibitor, is indicated for the treatment of patients with multiple myeloma. Multiple myeloma (multiple myeloma, MM) is a malignant tumor originating from the B cell lineage, characterized by the clonal proliferation of malignant plasma cells in the bone marrow microenvironment, causing fractures and bone marrow failure, and is the second most common blood system disease in the world Tumors cannot be cured by traditional chemotherapy regimens. Bortezomib is the
Huateng Pharma Develops Intermediates of Semaglutide For TD2
According to the latest IDF Diabetes map, the global prevalence of diabetes reached 10.5% in 2021, with 537 million adults living with diabetes. China has become a disaster zone for diabetes, with the largest number of adults with diabetes in the world. In the past 10 years (2011-2021), the number of people with diabetes in China increased from 90 million to 140 million, an increase of 56%. The total number
The Future of Treatment For Type 2 Diabetes
Although the treatment of type 2 diabetes (T2DM) has made impressive progress in the past few decades, researchers are constantly searching for new treatments. How to better control blood glucose and reduce diabetes-related complications has become a hot topic in the field of T2DM research. Previously, The Lancet Diabetes Endocrinology published an in-depth review detailing novel therapeutic targets for T2DM, mechanisms of drug action, and corresponding hypoglycemic efficacy. It involves innovation

All 5 Releases


More Releases for UVB

UVB Filters for Personal Care Market Outlook 2022: Business overview, Industry i …
Market Summary A newly published report titled "UVB Filters for Personal Care Market" by QY Research throws light on the industry dynamics and current and future trends that play a key role in determining the business expansion. The report also highlights the key driving factors and restraints that are impacting the growth. For a comprehensive understanding, the professionals have reviewed the regulatory scenario, market entry strategies, best industry practices, pricing strategy,
UV Sensors Market Report 2018: Segmentation by Product (UVA, UVB, UVC, Others) b …
Global UV Sensors market research report provides company profile for Davis Instruments, ST Microelectronics, Vernier, Panasonic Electronic Components, Vishay Semiconductor Opto, Solar Light, Silicon Labs, LAPIS Semiconductor and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to
Strategic Collaborations of Companies in the Developing Countries is Expected to …
Phototherapy is the treatment of disease or disorder by exposure to ultraviolet or infrared radiation. The main types of phototherapy broadband are UVA (PUVA and UVA1) and UVB. The most used phototherapy broadband is narrow band UVB light, which is less than 1% of the total wavelength from sunlight and has maximum absorption at wavelength at 311 nm. The patient is exposed to the selected monochromatic spectrum for a defined
Phototherapy Equipment Market Analysis by Key Growth Factors and Opportunities F …
Phototherapy is the treatment of disease or disorder by exposure to ultraviolet or infrared radiation. The main types of phototherapy broadband are UVA (PUVA and UVA1) and UVB. The most used phototherapy broadband is narrow band UVB light, which is less than 1% of the total wavelength from sunlight and has maximum absorption at wavelength at 311 nm. The patient is exposed to the selected monochromatic spectrum for a defined
03-17-2017 | Health & Medicine
TMR
Global Phototherapy Equipment Market is Driven by Increasing Demand from Health …
Phototherapy is the treatment of disease or disorder by exposure to ultraviolet or infrared radiation. The main types of phototherapy broadband are UVA (PUVA and UVA1) and UVB. The most used phototherapy broadband is narrow band UVB light, which is less than 1% of the total wavelength from sunlight and has maximum absorption at wavelength at 311 nm. The patient is exposed to the selected monochromatic spectrum for a defined
Phototherapy Equipment Market Future Trends and Key Industry Dynamics 2016 - 202 …
Phototherapy is the treatment of disease or disorder by exposure to ultraviolet or infrared radiation. The main types of phototherapy broadband are UVA (PUVA and UVA1) and UVB. The most used phototherapy broadband is narrow band UVB light, which is less than 1% of the total wavelength from sunlight and has maximum absorption at wavelength at 311 nm. The patient is exposed to the selected monochromatic spectrum for a defined